Consistent with previous results, the mice that received GPR132−/− bone marrow cells exhibited a higher proportion of NK cells in peripheral blood and inside the tumor as well as showed stronger resistance to melanoma compared to the WT group (Fig. 2J and fig. The gene discussed is GPR132; the disease is melanoma.